戊型肝炎疫苗在妊娠期的安全性:南苏丹本提乌境内流离失所者营地大规模应急接种运动后的模拟目标试验
在南苏丹本提乌境内流离失所者营地开展模拟目标试验,比较妊娠期接种戊型肝炎疫苗与未接种者的胎儿丢失风险。在匹配分析的2407名妇女中,妊娠期接种者胎儿丢失累积风险为7.2%(95%CI 5.6-8.7),未接种者为6.1%(95%CI 3.7-9.2),风险比为1.2(95%CI 0.7-1.9)。未发现妊娠期接种增加胎儿丢失风险的证据。
要点
- 妊娠期接种戊型肝炎疫苗者胎儿丢失累积风险为7.2%(95%CI 5.6-8.7)。
- 未接种者胎儿丢失累积风险为6.1%(95%CI 3.7-9.2)。
- 风险比为1.2(95%CI 0.7-1.9),未发现风险增加的证据。
核心结论
- 未发现妊娠期接种戊型肝炎疫苗增加胎儿丢失风险的证据。
研究设计与样本
- 模拟目标试验;在第二剂接种后对本提乌境内流离失所者营地开展全面妊娠普查。
- 纳入14-45岁、当前无黄疸或急性疾病的女性;同意者于分娩日期后28天随访记录妊娠结局。
- 共纳入3421名参与者进行随访分析;在接种运动开始后有妊娠结局的2741名妇女中,67名(2.4%)在受孕前接种,2036名(74.3%)在妊娠期接种,638名(23.2%)未接种。
- 按年龄、孕龄和接种倾向评分将接种者与未接种者匹配;在竞争风险框架下采用Aalen-Johansen估计量估计胎儿丢失累积发生率。
- 匹配分析保留2407名妇女。
主要发现
- 妊娠期接种者胎儿丢失累积风险为7.2%(95%CI 5.6-8.7),未接种者为6.1%(95%CI 3.7-9.2)。
- 风险比为1.2(95%CI 0.7-1.9)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Epidemic forms of hepatitis E cause high mortality among pregnant people, with case fatality risks over 30% and adverse fetal outcomes. In 2022, the first mass reactive vaccination campaign against hepatitis E was conducted in South Sudan with the HEV239 vaccine. We aimed to assess whether vaccination against hepatitis E in pregnancy increases the risk of fetal loss in a cohort of vaccinated and unvaccinated pregnant people. METHODS: In this emulated target trial, an exhaustive pregnancy census was conducted in Bentiu internally displaced persons camp after the second of three vaccination rounds. Women and girls aged 14-45 years with no current jaundice or acute illness were eligible for participation. Individuals who consented were revisited 28 days after their delivery date to document the pregnancy outcome. We used an emulated target trial framework to address biases inherent in observational studies. We matched vaccinated to unvaccinated participants on age, gestational age, and vaccination propensity score and estimated cumulative incidence functions for fetal loss in vaccinated compared to unvaccinated women in a competing risks framework using the Aalen-Johansen estimator. FINDINGS: Between May 16 and June 30, 2022, 3421 participants were enrolled and followed up for inclusion in analysis. Among 2741 women who had a pregnancy outcome after the start of the vaccination campaign, 67 (2·4%) were vaccinated before conception, 2036 (74·3%) were vaccinated during pregnancy, and 638 (23·2%) were not vaccinated. Among the 2407 women retained in the matched analyses, the cumulative risk of fetal loss among individuals vaccinated during pregnancy was 7·2% (95% CI 5·6-8·7) compared with 6·1% (3·7-9·2) among unvaccinated individuals, implying a risk ratio of 1·2 (95% CI 0·7-1·9). INTERPRETATION: No evidence of increased risk of fetal loss was found among individuals vaccinated during pregnancy. FUNDING: Médecins Sans Frontières.
引用
- Nesbitt RC, Azman AS, Asilaza VK, et al. Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South Sudan. Lancet Glob Health. 2024. PMID: 39424575. doi:10.1016/S2214-109X(24)00321-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。